Spots Global Cancer Trial Database for decadron
Every month we try and update this database with for decadron cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | NCT01983969 | Advanced Cancer... Lymphoma | Azacitidine Vorinostat Gemcitabine Busulfan Melphalan Dexamethasone Caphosol Glutamine Pyridoxine Rituximab | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors | NCT00088166 | Brain Edema Brain Tumor | hCRF placebo hCRF | 18 Years - | Celtic Pharma Development Services | |
| Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) | NCT02473042 | Post-Operative ... Breast Cancer | Electrical Stim... Zofran Dexamethasone Phenergan Pepcid Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma | NCT02532192 | Lymphoma | Belinostat Rituximab Cisplatin Cytarabine Dexamethasone Ciprofloxacin Fluconazole | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| Dexamethasone Dyspnea Study | NCT01670097 | Advanced Cancer... Hematologic Dis... Solid Tumors | Dexamethasone Placebo Questionnaires Spirometer Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Trimodality Management of T1b Esophageal Cancers | NCT01217060 | Esophageal Canc... | Docetaxel 5-FU Radiotherapy Esophagectomy Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage | NCT00890656 | Acute Lymphobla... | Cyclophosphamid... Vincristine Doxorubicin Decadron G-CSF Methotrexate (M... Ara-C Pegaspargase | - | M.D. Anderson Cancer Center | |
| Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer | NCT00507858 | Head and Neck C... | Pemetrexed Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | NCT02114502 | Myeloma | Carfilzomib SAHA Gemcitabine Busulfan Melphalan Stem Cell Trans... Palifermin Dexamethasone Caphosol Glutamine Pyridoxine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) | NCT02473042 | Post-Operative ... Breast Cancer | Electrical Stim... Zofran Dexamethasone Phenergan Pepcid Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes | NCT01692197 | Leukemia | E7070 Idarubicin Cytarabine Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma | NCT02106988 | Lymphoma | Radiation Thera... Dexamethasone Etoposide phosp... Ifosfamide Mesna Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | NCT00577993 | Lymphoma | Fludarabine Novantrone Decadron Rituximab Interferon Doxorubicin Vincristine Bleomycin Cyclophosphamid... Etoposide Cisplatin Ara-C Methyl-Predniso... Procarbazine Prednisone | - 76 Years | M.D. Anderson Cancer Center | |
| Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) | NCT01926665 | Lymphoma | Carfilzomib Dexamethasone | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer | NCT01455389 | Lung Cancer | DOTAP:Chol-TUSC... Erlotinib Dexamethasone Diphenhydramine | 18 Years - | Genprex, Inc. | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| VELCADE,Rituximab,Cyclophosphamide and Decadron | NCT00413959 | Lymphoma, Non-H... Lymphoma, B-Cel... | VELCADE® Rituximab Cyclophosphamid... Decadron | 18 Years - 90 Years | Oncology Specialists, S.C. | |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer | NCT01455389 | Lung Cancer | DOTAP:Chol-TUSC... Erlotinib Dexamethasone Diphenhydramine | 18 Years - | Genprex, Inc. | |
| R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | NCT00450801 | Lymphoma | Rituximab Cyclophosphamid... Cytarabine Doxorubicin Etoposide Ifosfamide Leucovorin Methotrexate Thalidomide Vincristine Mesna Filgrastim (G-C... Granisetron Decadron | 18 Years - | University of Miami | |
| Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma | NCT00290511 | Lymphoma | Fludarabine Mitoxantrone Rituximab Zevalin Dexamethasone | 60 Years - | M.D. Anderson Cancer Center | |
| Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger | NCT00290498 | Lymphoma | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate Cytarabine Prednisone | 16 Years - 60 Years | M.D. Anderson Cancer Center | |
| Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) | NCT01531998 | Myeloma | Lenalidomide Bortezomib Siltuximab Dexamethasone Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Thalidomide-Dexamethasone for Multiple Myeloma | NCT00038090 | Multiple Myelom... | Thalidomide Dexamethasone | - | M.D. Anderson Cancer Center | |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) | NCT02464657 | Leukemia Acute Myeloid L... Myelodysplastic... | Nivolumab Idarubicin Cytarabine Solu-medrol Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis | NCT02740127 | Malignant Neopl... | Caudal Nerve Bl... Ropivacaine Epinephrine Decadron Clonidine Propofol Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients | NCT01440582 | Myeloma | Panobinostat Bortezomib Lenalidomide Dexamethasone Symptom Questio... | 18 Years - | M.D. Anderson Cancer Center | |
| Dexamethasone for Symptom Burden in Advanced Cancer Patients | NCT00489307 | Solid Tumors | Dexamethasone Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage | NCT00905034 | Leukemia, Lymph... | Methotrexate Vincristine PEG-l-asparagin... Dexamethasone Rituximab | 1 Year - | M.D. Anderson Cancer Center | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center | |
| High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma | NCT01237951 | Myeloma | Palifermin Dexamethasone Gemcitabine Busulfan Melphalan Stem Cell Trans... G-CSF | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma | NCT03283046 | Malignant Neopl... Multiple Myelom... | Nivolumab Lenalidomide Dexamethasone Ipilimumab | 18 Years - | M.D. Anderson Cancer Center | |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | NCT02589145 | Lymphoma | Lenalidomide Vorinostat Gemcitabine Busulfan Melphalan Rituximab Dexamethasone Caphosol Glutamine Pyridoxine Enoxaparin Stem Cell Trans... Palifermin | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center | |
| XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors | NCT00088166 | Brain Edema Brain Tumor | hCRF placebo hCRF | 18 Years - | Celtic Pharma Development Services |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
